ASCENT研究:改善肾移植等待名单登记并减少种族差异的随机有效性-实施研究
美国2014年实施新肾脏分配系统(KAS),预期减少等待名单上的种族差异,但部分透析机构临床医生和ESRD患者不了解政策变化。ASCENT研究是一项随机对照有效性-实施研究,设计多组分干预(教育网络研讨会、患者和员工教育视频、机构特异性移植绩效反馈报告),计划纳入约600家等待名单登记率低的美国透析机构。共同主要结局为1年时等待名单登记变化和等待名单差异,次要结局包括医疗主任知识、员工培训、患者教育和转诊意图的变化。
要点
- ASCENT研究评估多组分干预能否提高透析机构肾移植等待名单登记并减少种族差异。
- 干预包括对医疗主任的网络研讨会、患者和员工教育视频及机构特异性绩效反馈报告。
- 计划纳入约600家等待名单登记率低的美国透析机构,覆盖全部18个ESRD网络。
核心结论
- ASCENT研究结果将展示多组分干预增加 deceased-donor 肾移植等待名单准入并减少等待名单登记种族差异的可行性和有效性。
研究设计与样本
- 随机对照有效性-实施研究,计划纳入约600家等待名单登记率低的美国透析机构,覆盖全部18个ESRD网络。
主要发现
- 研究尚在进行中,未报告主要结局结果。
关键数值与推荐
- 共同主要结局为1年时等待名单登记变化和等待名单差异。
- 次要结局包括机构医疗主任对KAS知识的变化、员工关于KAS培训的变化、患者移植教育的变化以及医疗主任转诊患者进行移植评估的意图变化。
临床怎么用
- 干预材料由多学科传播咨询委员会开发,并在美国透析机构进行形成性测试。
- 干预包括对透析医疗主任的教育网络研讨会、对患者的教育视频、对透析员工的教育视频以及透析机构特异性移植绩效反馈报告。
局限性
- 原文未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The United Network for Organ Sharing (UNOS) implemented a new Kidney Allocation System (KAS) in December 2014 that is expected to substantially reduce racial disparities in kidney transplantation among waitlisted patients. However, not all dialysis facility clinical providers and end stage renal disease (ESRD) patients are aware of how the policy change could improve access to transplant. METHODS: We describe the ASCENT (Allocation System Changes for Equity in KidNey Transplantation) study, a randomized controlled effectiveness-implementation study designed to test the effectiveness of a multicomponent intervention to improve access to the early steps of kidney transplantation among dialysis facilities across the United States. The multicomponent intervention consists of an educational webinar for dialysis medical directors, an educational video for patients and an educational video for dialysis staff, and a dialysis-facility specific transplant performance feedback report. Materials will be developed by a multidisciplinary dissemination advisory board and will undergo formative testing in dialysis facilities across the United States. RESULTS: This study is estimated to enroll ~600 U.S. dialysis facilities with low waitlisting in all 18 ESRD Networks. The co-primary outcomes include change in waitlisting, and waitlist disparity at 1 year; secondary outcomes include changes in facility medical director knowledge about KAS, staff training regarding KAS, patient education regarding transplant, and a medical director's intent to refer patients for transplant evaluation. CONCLUSION: The results from the ASCENT study will demonstrate the feasibility and effectiveness of a multicomponent intervention designed to increase access to the deceased-donor kidney waitlist and reduce racial disparities in waitlisting.
引用
- Patzer RE, Smith K, Basu M, et al. The ASCENT (Allocation System Changes for Equity in Kidney Transplantation) Study: a Randomized Effectiveness-Implementation Study to Improve Kidney Transplant Waitlisting and Reduce Racial Disparity. Kidney Int Rep. 2017. PMID: 28845470. doi:10.1016/j.ekir.2017.02.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。